4432 |
[Featured Lecture 1] CABG vs PCI in Left Main Disease: What Does the Randomised Data Really Tell Us |
Adrian P. Banning |
Apr. 20. 23 |
4431 |
Start Tailored Approach on Cholesterol Management for ASCVD Patients |
Jung Ho Heo |
Apr. 20. 23 |
4430 |
Eagle's Eye View: How to Get Patients on a Statin Timely and Keep Them on It |
Duk-Woo Park |
Apr. 20. 23 |
4429 |
Individual Treatment Strategy for Dyslipidemia in CAD |
Wonjae Lee |
Apr. 20. 23 |
4428 |
Real World Experience of D+STORM DES |
Hyoung-Mo Yang |
Apr. 20. 23 |
4427 |
TAVR Remaining Unmet Needs: Valve in Valve |
Cheol Woong Yu |
Apr. 20. 23 |
4426 |
TAVR Durability: Leaftlet Thrombosis and HALT |
Jeehoon Kang |
Apr. 20. 23 |
4425 |
Case presentation 1: Optimize the Vessel Preparation for a Wide Range of Lesions Treatment with DCB |
Takuma Tsuda |
Apr. 20. 23 |
4424 |
Time to Move Beyond ISR - How and When Should I Consider Drug Coated Balloon (AGENT) to Treat De Novo Lesions? |
Seung Hun Lee |
Apr. 20. 23 |
4423 |
Imaging Guided PCI vs. Angio Guided PCI Focus on OCT |
Joo-Yong Hahn |
Apr. 20. 23 |